Fengli Hu
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study.
Journal: Translational cancer research
Published: June 19, 2022
Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma.
Journal: Aging
Published: May 04, 2020
PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers.
Journal: Nanoscale research letters
Published: July 03, 2019
Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress.
Journal: PloS one
Published: May 30, 2015
Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.
Journal: Molecular cancer therapeutics
Published: April 08, 2014
Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation.
Journal: Apoptosis : an international journal on programmed cell death
Published: October 12, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026